Colorado · 86301

Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in Colorado

Colorado Medicare Avg
$20.39
0% above national avg
National Medicare Avg
$20.37
All states combined
Billed Charge (CO)
$165.16
What providers submit
Est. Commercial (CO)
$46.90
National avg: $45.62
Est. Cash / Self-Pay (CO)
$60.71
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

380
Services in CO
5
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Colorado

Provider Medicare Services
Laboratory Corporation Of America $20.39 373

Colorado Pricing in Context

In Colorado, CPT code 86301 (Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9) carries an average Medicare payment of $20.39 — 0% above the national benchmark of $20.37. 5 providers across the state submitted claims for this procedure in 2023, performing 380 total services. Individual payments in CO ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Colorado is $165.16, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Colorado sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Colorado lands near $46.90, with self-pay cash prices typically around $60.71. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cost in Colorado?

The average Medicare payment for Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in Colorado is $20.39, which is 0% above the national average of $20.37. Providers in CO typically bill $165.16 for this procedure.

What does Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cost with insurance in Colorado?

With commercial insurance in Colorado, Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 costs an estimated $46.90. Without insurance, the estimated cash price is $60.71. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in Colorado?

5 providers in Colorado billed Medicare for Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in 2023, performing 380 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cheaper in Colorado than the national average?

No — Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 costs 0% above the national average in Colorado. The state average Medicare payment is $20.39 compared to $20.37 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial